Mead Johnson Nutrition Company (MJN) has been under a strong bear grip, hence the stock is down -5.66% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.68% in the past 1 week. The stock has risen by 0.84% in the past week indicating that the buyers are active at lower levels, but the stock is down -6.16% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 0.39% and the 50-Day Moving Average is 5.68%.The 200 Day SMA reached 2%
Mead Johnson Nutrition Company (NYSE:MJN): After opening at $78.65, the stock dipped to an intraday low of $78.39 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $79.23 and the buying power remained strong till the end. The stock closed at $79.01 for the day, a gain of 0.98% for the day session. The total traded volume was 1,185,875. The stocks close on the previous trading day was $79.01.
Mead Johnson Nutrition Company (MJN) : The highest short term price target forecast on Mead Johnson Nutrition Company (MJN) is $96 and the lowest target price is $75. A total of 7 equity analysts are currently covering the company. The average price of all the analysts is $87 with a standard deviation of $6.43.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.